Knight Therapeutics (GUD) Stock Chart & Stock Price History C$5.85 -0.06 (-1.02%) As of 10/7/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock Knight Therapeutics Stock Price Performance The Knight Therapeutics (GUD) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 0.85%, with a year-to-date return of 9.55%. In the past month, the stock has decreased 9.30%, reflecting recent market activity. As of the latest close, Knight Therapeutics traded at C$5.85 with a market cap of C$582.97 million and volume of 72,500 shares. Five years ago, the stock traded at C$5.53, representing a 5.79% increase over that period. At the time, it had a market cap of C$724.09 million and a volume of 208,086 shares. Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance0.00%1 Month Performance-9.30%3 Month Performance-3.78%Year-To-Date Performance+9.55%1 Year Performance-0.85%5 Year Performance+5.79% GUD Stock Chart for Wednesday, October, 8, 2025 GUD Chart by TradingView Knight Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/07/2025C$5.91C$5.85-1.02%C$5.92C$5.8072,500 shsC$582.97 million10/06/2025C$5.85C$5.91+1.03%C$5.93C$5.8544,516 shsC$588.95 million10/03/2025C$5.83C$5.85+0.34%C$5.91C$5.8343,167 shsC$582.97 million10/02/2025C$5.93C$5.83-1.69%C$5.96C$5.8324,902 shsC$580.98 million10/01/2025C$5.88C$5.93+0.85%C$6.01C$5.8138,000 shsC$590.94 million09/30/2025C$5.92C$5.88-0.68%C$5.92C$5.8827,199 shsC$585.96 million09/29/2025C$5.93C$5.92-0.17%C$6.01C$5.8842,210 shsC$589.95 million09/26/2025C$6.08C$5.93-2.47%C$6.08C$5.9346,390 shsC$590.94 million09/25/2025C$6.07C$6.08+0.16%C$6.09C$6.0449,193 shsC$605.89 million09/24/2025C$6.04C$6.07+0.50%C$6.11C$6.0430,462 shsC$604.89 million Get the Latest News and Ratings for GUD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/23/2025C$6.18C$6.04-2.27%C$6.17C$6.0342,928 shsC$615.86 million09/22/2025C$6.23C$6.18-0.80%C$6.23C$6.1345,983 shsC$615.86 million09/19/2025C$6.20C$6.23+0.48%C$6.26C$6.16134,728 shsC$620.84 million09/18/2025C$6.23C$6.20-0.48%C$6.25C$6.2027,910 shsC$617.85 million09/17/2025C$6.30C$6.23-1.11%C$6.37C$6.2056,308 shsC$620.84 million09/16/2025C$6.35C$6.30-0.79%C$6.34C$6.2843,465 shsC$627.81 million09/15/2025C$6.34C$6.35+0.16%C$6.35C$6.2741,599 shsC$632.80 million09/12/2025C$6.43C$6.34-1.40%C$6.45C$6.3269,371 shsC$631.80 million09/11/2025C$6.40C$6.43+0.47%C$6.44C$6.3786,135 shsC$640.77 million09/10/2025C$6.43C$6.40-0.47%C$6.45C$6.4030,746 shsC$637.78 million09/09/2025C$6.45C$6.43-0.31%C$6.47C$6.3527,938 shsC$640.77 million09/08/2025C$6.44C$6.45+0.16%C$6.47C$6.3278,385 shsC$642.76 million Related Companies CRON Stock Price Chart DHT.UN Stock Price Chart WEED Stock Price Chart ACB Stock Price Chart CPH Stock Price Chart OGI Stock Price Chart SUGR Stock Price Chart HLS Stock Price Chart RX Stock Price Chart CRDL Stock Price Chart Receive GUD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Knight Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:GUD) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Knight Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Knight Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
